Download PDF
Klin Monbl Augenheilkd 2019; 236(05): 662-666
DOI: 10.1055/a-0874-2394
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Peri-/Postoperative antientzündliche Therapie im Rahmen von vitreoretinalen Eingriffen

Peri-/Postoperative Anti-Inflammatory Therapy in Vitreoretinal Interventions
Nicolas Feltgen
1   Klinik für Augenheilkunde, Universitätsmedizin Göttingen
,
Hansjürgen Agostini
2   Augenklinik, Universitätsklinikum Freiburg
,
Albrecht Peter Lommatzsch
3   Retinologie, Augenabteilung am St. Franziskus Hospital Münster
,
Friederike Schaub
4   Augenklinik, Universitätsklinikum Köln
,
Hans Hoerauf
1   Klinik für Augenheilkunde, Universitätsmedizin Göttingen
› Author Affiliations
Further Information

Publication History

eingereicht 25 February 2019

akzeptiert 01 March 2019

Publication Date:
16 May 2019 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die perioperative Behandlung netzhautchirurgischer Eingriffe mit entzündungshemmenden Medikamenten ist für Augenärzte in Deutschland eine alltägliche Maßnahme. Trotzdem liegen erstaunlich wenige Daten vor, die eine Wirksamkeit nach vitreoretinaler Chirurgie untersuchen. Behandelt wird i. d. R. in Analogie zu Eingriffen am vorderen Augenabschnitt, für die wesentlich robustere Daten vorliegen. In diesem Beitrag sollen die relevanten klinischen Fragen beantwortet und soweit möglich, mit Studiendaten belegt werden.

Abstract

The perioperative treatment of retinal surgery with anti-inflammatory drugs is an everyday procedure for ophthalmologists in Germany. Nevertheless, little data are available to investigate the efficacy of vitreoretinal surgery. Treatment is usually analogous to procedures on the anterior segment of the eye, for which much more robust data are available. In this article, the relevant clinical questions will be answered and, when possible, documented with study data.

Schlüsselwörter

Steroide - Ablatio retinae - Inflammation - Makula - Netzhaut

Key words

steroids - retinal detachment - inflammation - macula - retina
 

  • Literatur

  • 1 Hoshi S, Okamoto F, Hasegawa Y. et al. Time course of changes in aqueous flare intensity after vitrectomy for rhegmatogenous retinal detachment. Retina (Philadelphia, Pa) 2012; 32: 1862-1867
    CrossrefPubMedGoogle Scholar
  • 2 Ramulu PY, Do DV, Corcoran KJ. et al. Use of retinal procedures in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol 2010; 128: 1335-1340
    CrossrefPubMedGoogle Scholar
  • 3 Aptel F, Colin C, Kaderli S. et al. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol 2017; 101: 1-10
    PubMedGoogle Scholar
  • 4 Chalam KV, Malkani S, Shah VA. Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery. Ophthalmic Surg Lasers Imaging 2003; 34: 188-192
    PubMedGoogle Scholar
  • 5 Hoerster R, Hermann MM, Rosentreter A. et al. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment. Br J Ophthalmol 2013; 97: 450-453
    CrossrefPubMedGoogle Scholar
  • 6 Schaub F, Hoerster R, Schiller P. et al. Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial. Trials 2018; 19: 384
    CrossrefPubMedGoogle Scholar
  • 7 Kim SJ, Lo WR, Hubbard GB. et al. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. Arch Ophthalmol 2008; 126: 1203-1208
    CrossrefPubMedGoogle Scholar
  • 8 Naithani P, Puranik S, Vashisht N. et al. Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery. Retina (Philadelphia, Pa) 2012; 32: 250-255
    CrossrefPubMedGoogle Scholar
  • 9 Ben Yahia S, Kahloun R, Abroug N. et al. Comparative effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment surgery. Int Ophthalmol 2016; 36: 623-628
    CrossrefPubMedGoogle Scholar
  • 10 Nagpal M, Lambat S, Mehrotra N. et al. Topical nepafenac 0.1 % alone versus prednisolone acetate 1 % as postoperative anti-inflammatory agents in small gauge vitrectomy. Indian J Ophthalmol 2014; 62: 606-609
    CrossrefPubMedGoogle Scholar
  • 11 Heier JS, Awh CC, Busbee BG. et al. Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4 %, bromfenac 0.09 %, and nepafenac 0.1 %. Retina (Philadelphia, Pa) 2009; 29: 1310-1313
    CrossrefPubMedGoogle Scholar
  • 12 Burton TC, Stevens TS, Harrison TJ. The influence of subconjunctival depot corticosteroid on choroidal detachment following retinal detachment surgery. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1975; 79: OP845-9
    PubMedGoogle Scholar
  • 13 Weijtens O, Feron EJ, Schoemaker RC. et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol 1999; 128: 192-197
    CrossrefPubMedGoogle Scholar
  • 14 Paccola L, Jorge R, Barbosa JC. et al. Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1 % eyedrops after pars plana vitrectomy. Acta Ophthalmol Scand 2007; 85: 603-608
    CrossrefPubMedGoogle Scholar
  • 15 Mardin C. Perioperative Therapie. In: Erb C, Schlote T. Medikamentöse Augentherapie. 6. Aufl.. Stuttgart: Thieme; 2016: 535-548
    Google Scholar
  • 16 Yamakiri K, Sakamoto T, Noda Y. et al. One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 959-966
    CrossrefPubMedGoogle Scholar
  • 17 Jaissle GB, Szurman P, Völker M. et al. Epiretinal deposit of triamcinolone acetonide at the posterior pole after intravitreal injection. Ophthalmic Surg Lasers Imaging 2007; 38: 238-241
    CrossrefPubMedGoogle Scholar
  • 18 Pastor JC, Rojas J, Pastor-Idoate S. et al. Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res 2016; 51: 125-155
    CrossrefPubMedGoogle Scholar
  • 19 Conart JB, Kurun S, Ameloot F. et al. Validity of aqueous flare measurement in predicting proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Acta Ophthalmol 2017; 95: e278-e283
    CrossrefPubMedGoogle Scholar
  • 20 Schröder S, Muether PS, Caramoy A. et al. Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Retina (Philadelphia, Pa) 2012; 32: 38-42
    CrossrefPubMedGoogle Scholar
  • 21 Koerner F, Koerner-Stiefbold U, Garweg JG. Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial. Graefes Arch Clin Exp Ophthalmol 2012; 250: 981-987
    CrossrefPubMedGoogle Scholar
  • 22 Ritter M, Sacu S, Matt G. et al. Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane: a randomized, controlled clinical study. Eye (Lond) 2011; 25: 1284-1293
    CrossrefPubMedGoogle Scholar
  • 23 Rezar S, Sacu S, Ritter M. et al. [Influence of postoperative oral steroid treatment on retinal sensitivity in patients after macular surgery. A randomized, controlled, clinical trial]. Ophthalmologe 2014; 111: 31-36
    CrossrefPubMedGoogle Scholar
  • 24 Huang OS, Mehta JS, Htoon HM. et al. Incidence and risk factors of elevated intraocular pressure following deep anterior lamellar keratoplasty. Am J Ophthalmol 2016; 170: 153-160
    CrossrefPubMedGoogle Scholar
  • 25 Baartman BJ, Gans R, Goshe J. Prednisolone versus dexamethasone for prevention of pseudophakic cystoid macular edema. Can J Ophthalmol 2018; 53: 131-134
    CrossrefPubMedGoogle Scholar
  • 26 Ostrov CS, Sirkin SR, Deutsch WE. et al. Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clin Ther 1997; 19: 259-272
    CrossrefPubMedGoogle Scholar
  • 27 Awan MA, Agarwal PK, Watson DG. et al. Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance. Br J Ophthalmol 2009; 93: 708-713
    CrossrefPubMedGoogle Scholar